146 related articles for article (PubMed ID: 33278841)
21. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
22. Changes in von Willebrand Factor Multimers, Concentration, and Function During Pediatric Extracorporeal Membrane Oxygenation.
Van Den Helm S; Letunica N; Barton R; Weaver A; Yaw HP; Karlaftis V; McCafferty C; Cai T; Newall F; Horton SB; Chiletti R; Johansen A; Best D; McKittrick J; Butt W; d'Udekem Y; MacLaren G; Linden MD; Ignjatovic V; Monagle P
Pediatr Crit Care Med; 2023 Apr; 24(4):268-276. PubMed ID: 36602314
[TBL] [Abstract][Full Text] [Related]
23. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
24. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
25. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
[TBL] [Abstract][Full Text] [Related]
26. Relatively increased von Willebrand factor activity after off-pump coronary artery bypass graft surgery.
Lo B; Nierich AP; Kalkman CJ; Fijnheer R
Thromb Haemost; 2007 Jan; 97(1):21-6. PubMed ID: 17200766
[TBL] [Abstract][Full Text] [Related]
27. Release of von Willebrand factor by cardiopulmonary bypass, but not by cardioplegia in open heart surgery.
Valen G; Blombäck M; Sellei P; Lindblom D; Vaage J
Thromb Res; 1994 Jan; 73(1):21-9. PubMed ID: 8178310
[TBL] [Abstract][Full Text] [Related]
28. Changes in factor VIII proteins after cardiopulmonary bypass in man suggest endothelial damage.
Jones DK; Luddington R; Higenbottam TW; Scott J; Cavarocchi N; Reardon D; Calvin J; Wallwork J
Thromb Haemost; 1988 Oct; 60(2):199-204. PubMed ID: 2975406
[TBL] [Abstract][Full Text] [Related]
29. Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay.
Riddell AF; Jenkins PV; Nitu-Whalley IC; McCraw AH; Lee CA; Brown SA
Br J Haematol; 2002 Jan; 116(1):187-92. PubMed ID: 11841416
[TBL] [Abstract][Full Text] [Related]
30. Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
Nakajima Y; Nogami K; Yada K; Ogiwara K; Furukawa S; Shimonishi N; Shima M
Haemophilia; 2019 May; 25(3):e174-e179. PubMed ID: 30866149
[TBL] [Abstract][Full Text] [Related]
31. Laboratory Testing for von Willebrand Factor Ristocetin Cofactor (VWF:RCo).
Mohammed S; Favaloro EJ
Methods Mol Biol; 2017; 1646():435-451. PubMed ID: 28804846
[TBL] [Abstract][Full Text] [Related]
32. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis.
Casonato A; Sartorello F; Pontara E; Gallinaro L; Bertomoro A; Grazia Cattini M; Daidone V; Szukowska M; Pagnan A
Thromb Haemost; 2007 Dec; 98(6):1182-7. PubMed ID: 18064311
[TBL] [Abstract][Full Text] [Related]
33. Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.
Favaloro EJ; Mohammed S
Thromb Res; 2014 Dec; 134(6):1292-300. PubMed ID: 25300811
[TBL] [Abstract][Full Text] [Related]
34. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
[TBL] [Abstract][Full Text] [Related]
35. von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease.
Gill JC; Shapiro A; Valentino LA; Bernstein J; Friedman C; Nichols WL; Manco-Johnson M
Haemophilia; 2011 Nov; 17(6):895-905. PubMed ID: 21535320
[TBL] [Abstract][Full Text] [Related]
36. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
37. An update on the von Willebrand factor collagen binding assay: 21 years of age and beyond adolescence but not yet a mature adult.
Favaloro EJ
Semin Thromb Hemost; 2007 Nov; 33(8):727-44. PubMed ID: 18175279
[TBL] [Abstract][Full Text] [Related]
38. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
[TBL] [Abstract][Full Text] [Related]
39. The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor.
Holdright DR; Hunt BJ; Parratt R; Segal H; Clarke D; Taggart D; Bennett G; Collins P
Eur J Cardiothorac Surg; 1995; 9(1):18-21. PubMed ID: 7727141
[TBL] [Abstract][Full Text] [Related]
40. Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies.
Favaloro EJ; Oliver S; Mohammed S; Vong R
Haemophilia; 2020 May; 26(3):503-512. PubMed ID: 32159272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
